|
Innovative medications emerging from clinical trials are not only helping with weight loss but also improving heart health, blood sugar control, liver function, and more.
With obesity rates rising worldwide, QPS is leading the charge in global clinical research, offering full-service CRO clinical trial support and expert teams to advance these transformative treatments.
This QPS white paper explores the global obesity epidemic and highlights promising therapies, from GLP-1 receptor agonists to inflammation-targeting drugs, that offer wide-ranging benefits beyond weight management.
|